MicroRNA-296-5p (miR-296-5p) functions as a tumor suppressor in prostate cancer by directly targeting Pin1

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 2055-2066

  Lee, Kuen Haur ^a   Lin, Forn Chia ^b,c   Hsu, Tai I ^b   Lin, Jen Tai ^b,d   Guo, Jing Hong ^b   Tsai, Chen Hsun ^b   Lee, Yu Cheng ^b   Lee, Yu Chieh ^a   Chen, Chi Long ^e   Hsiao, Michael ^f   Lu, Pei Jung ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

MiR 296 5p; Pin1; Prostate cancer

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 296; PEPTIDYLPROLYL ISOMERASE PIN1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MALE; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROSTATE CANCER; RNA PROCESSING; TUMOR SUPPRESSOR GENE;

MIR-296-5P; PIN1; PROSTATE CANCER;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; PEPTIDYLPROLYL ISOMERASE; PROSTATIC NEOPLASMS; RNA, MESSENGER; UP-REGULATION;

EID: 84902653276     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.06.001     Document Type: Article

References (55)

1. Schutkowski M., Bernhardt A., Zhou X.Z., Shen M., Reimer U., Rahfeld J.U., Lu K.P., Fischer G. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry 1998, 37:5566-5575.
2. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
3. Ryo A., Liou Y.C., Wulf G., Nakamura M., Lee S.W., Lu K.P. PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells. Mol. Cell. Biol. 2002, 22:5281-5295.
4. MacLachlan T.K., Somasundaram K., Sgagias M., Shifman Y., Muschel R.J., Cowan K.H., El-Deiry W.S. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 2000, 275:2777-2785.
5. Lu P.J., Zhou X.Z., Liou Y.C., Noel J.P., Lu K.P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 2002, 277:2381-2384.
6. Eckerdt F., Yuan J., Saxena K., Martin B., Kappel S., Lindenau C., Kramer A., Naumann S., Daum S., Fischer G., Dikic I., Kaufmann M., Strebhardt K. Polo-like kinase 1-mediated phosphorylation stabilizes Pin1 by inhibiting its ubiquitination in human cells. J. Biol. Chem. 2005, 280:36575-36583.
7. Lee T.H., Pastorino L., Lu K.P. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev. Mol. Med. 2011, 13:e21.
8. Balastik M., Lim J., Pastorino L., Lu K.P. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?. Biochim. Biophys. Acta 2007, 1772:422-429.
9. Shen Z.J., Esnault S., Rosenthal L.A., Szakaly R.J., Sorkness R.L., Westmark P.R., Sandor M., Malter J.S. Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J. Clin. Invest. 2008, 118:479-490.
10. Lu K.P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 2003, 4:175-180.
11. Ryo A., Liou Y.C., Lu K.P., Wulf G. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 2003, 116:773-783.
12. Bao L., Kimzey A., Sauter G., Sowadski J.M., Lu K.P., Wang D.G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164:1727-1737.
13. Lu K.P., Suizu F., Zhou X.Z., Finn G., Lam P., Wulf G. Targeting carcinogenesis: a role for the prolyl isomerase Pin1?. Mol. Carcinog. 2006, 45:397-402.
14. Ayala G., Wang D., Wulf G., Frolov A., Li R., Sowadski J., Wheeler T.M., Lu K.P., Bao L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003, 63:6244-6251.
15. He J., Zhou F., Shao K., Hang J., Wang H., Rayburn E., Xiao Z.X., Lee S.W., Xue Q., Feng X.L., Shi S.S., Zhang C.Y., Zhang S. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer 2007, 56:51-58.
16. Pang R.W., Lee T.K., Man K., Poon R.T., Fan S.T., Kwong Y.L., Tse E. PIN1 expression contributes to hepatic carcinogenesis. J. Pathol. 2006, 210:19-25.
17. Tan X., Zhou F., Wan J., Hang J., Chen Z., Li B., Zhang C., Shao K., Jiang P., Shi S., Feng X., Lv N., Wang Z., Ling Y., Zhao X., Ding D., Sun J., Xiong M., He J. Pin1 expression contributes to lung cancer: prognosis and carcinogenesis. Cancer Biol. Ther. 2010, 9:111-119.
18. Han C.Y., Hien T.T., Lim S.C., Kang K.W. Role of Pin1 in UVA-induced cell proliferation and malignant transformation in epidermal cells. Biochem. Biophys. Res. Commun. 2011, 410:68-74.
19. Vaucheret H., Vazquez F., Crete P., Bartel D.P. The action of ARGONAUTE1 in the miRNA pathway and its regulation by the miRNA pathway are crucial for plant development. Genes Dev. 2004, 18:1187-1197.
20. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
21. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
22. Hime G.R., Somers W.G. Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells. Cell Adh. Migr. 2009, 3:425-432.
23. Iorio M.V., Croce C.M. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 2009, 27:5848-5856.
24. Shi X.B., Xue L., Yang J., Ma A.H., Zhao J., Xu M., Tepper C.G., Evans C.P., Kung H.J., deVere White R.W. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19983-19988.
25. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.
26. Vrba L., Jensen T.J., Garbe J.C., Heimark R.L., Cress A.E., Dickinson S., Stampfer M.R., Futscher B.W. Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One 2010, 5:e8697.
27. Lee K.H., Hsu E.C., Guh J.H., Yang H.C., Wang D., Kulp S.K., Shapiro C.L., Chen C.S. Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator. J. Biol. Chem. 2011, 286:39247-39258.
28. Obernosterer G., Martinez J., Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat. Protoc. 2007, 2:1508-1514.
29. Guh J.H., Chang W.L., Yang J., Lee S.L., Wei S., Wang D., Kulp S.K., Chen C.S. Development of novel adenosine monophosphate-activated protein kinase activators. J. Med. Chem. 2010, 53:2552-2561.
30. Bjorling E., Lindskog C., Oksvold P., Linne J., Kampf C., Hober S., Uhlen M., Ponten F. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol. Cell. Proteomics 2008, 7:825-844.
31. Ponten F., Jirstrom K., Uhlen M. The Human Protein Atlas-a tool for pathology. J. Pathol. 2008, 216:387-393.
32. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
33. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
34. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
35. John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. Human microRNA targets. PLoS Biol. 2004, 2:e363.
36. Betel D., Koppal A., Agius P., Sander C., Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010, 11:R90.
37. Liu B., Liu L., Tsykin A., Goodall G.J., Green J.E., Zhu M., Kim C.H., Li J. Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation. Bioinformatics 2010, 26:3105-3111.
38. Kong D., Li Y., Wang Z., Banerjee S., Ahmad A., Kim H.R., Sarkar F.H. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells 2009, 27:1712-1721.
39. Slabakova E., Pernicova Z., Slavickova E., Starsichova A., Kozubik A., Soucek K. TGF-beta1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug. Prostate 2011, 71:1332-1343.
40. Wei J.J., Wu X., Peng Y., Shi G., Basturk O., Yang X., Daniels G., Osman I., Ouyang J., Hernando E., Pellicer A., Rhim J.S., Melamed J., Lee P. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin. Cancer Res. 2011, 17:1297-1305.
41. Kruger J., Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 2006, 34:W451-W454.
42. Taylor B.S., Schultz N., Hieronymus H., Gopalan A., Xiao Y., Carver B.S., Arora V.K., Kaushik P., Cerami E., Reva B., Antipin Y., Mitsiades N., Landers T., Dolgalev I., Major J.E., Wilson M., Socci N.D., Lash A.E., Heguy A., Eastham J.A., Scher H.I., Reuter V.E., Scardino P.T., Sander C., Sawyers C.L., Gerald W.L. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010, 18:11-22.
43. Ryo A., Uemura H., Ishiguro H., Saitoh T., Yamaguchi A., Perrem K., Kubota Y., Lu K.P., Aoki I. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 2005, 11:7523-7531.
44. Khandelwal P., Padala M.K., Cox J., Guntaka R.V. The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1. Int. J. Cell Biol. 2009, 2009:243532.
45. Xu G.G., Etzkorn F.A. Pin1 as an anticancer drug target. Drug News Perspect. 2009, 22:399-407.
46. Chaudhuri K., Chatterjee R. MicroRNA detection and target prediction: integration of computational and experimental approaches. DNA Cell Biol. 2007, 26:321-337.
47. Vaira V., Faversani A., Dohi T., Montorsi M., Augello C., Gatti S., Coggi G., Altieri D.C., Bosari S. miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression. Oncogene 2012, 31:27-38.
48. Shivapurkar N., Mikhail S., Navarro R., Bai W., Marshall J., Hwang J., Pishvaian M., Wellstein A., He A.R. Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer. Int. J. Colorectal Dis. 2013, 28:887.
49. Vaira V., Faversani A., Martin N.M., Garlick D.S., Ferrero S., Nosotti M., Kissil J.L., Bosari S., Altieri D.C. Regulation of lung cancer metastasis by Klf4-Numb-like signaling. Cancer Res. 2013, 73:2695-2705.
50. Ishkanian A.S., Mallof C.A., Ho J., Meng A., Albert M., Syed A., van der Kwast T., Milosevic M., Yoshimoto M., Squire J.A., Lam W.L., Bristow R.G. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate 2009, 69:1091-1100.
51. Diana F., Di Bernardo J., Sgarra R., Tessari M.A., Rustighi A., Fusco A., Giancotti V., Manfioletti G. Differential HMGA expression and post-translational modifications in prostatic tumor cells. Int. J. Oncol. 2005, 26:515-520.
52. Michael A., Stephan C., Schnorr D., Loening S.A., Jung K. Serum macrophage migration inhibitory factor is not elevated in patients with prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2004, 13:328-329.
53. Carter H.B. Assessing risk: does this patient have prostate cancer?. J. Natl. Cancer Inst. 2006, 98:506-507.
54. Lill C., Schneider S., Pammer J., Loewe R., Gedlicka W., Houben R., Heiduschka G., Brunner M., Thurnher D. Significant correlation of peptidyl-prolyl isomerase overexpression in Merkel cell carcinoma with overall survival of patients. Head Neck 2011, 33:1294-1300.
55. Kuramochi J., Arai T., Ikeda S., Kumagai J., Uetake H., Sugihara K. High Pin1 expression is associated with tumor progression in colorectal cancer. J. Surg. Oncol. 2006, 94:155-160.